Venky's Q3FY26 Net Profit Surges 138% to ₹4,858 Lakhs on Higher Realisations

2 min read     Updated on 09 Feb 2026, 07:23 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Venky's (India) Limited delivered strong Q3FY26 results with net profit jumping 138.32% to ₹4,858 lakhs driven by improved realisations in poultry products. Revenue from operations grew 7.76% to ₹95,015 lakhs with the poultry segment contributing ₹49,123 lakhs. The company has filed regulatory compliance with NSE and BSE.

32190831

*this image is generated using AI for illustrative purposes only.

Venky's (India) Limited delivered robust financial performance in Q3FY26, with net profit surging 138.32% year-on-year to ₹4,858 lakhs. The poultry major's strong operational execution and improved market realisations drove the impressive growth trajectory during the quarter ended December 31, 2025.

Financial Performance Overview

The company's revenue from operations increased 7.76% to ₹95,015 lakhs in Q3FY26 compared to ₹88,161 lakhs in Q3FY25. Total income, including other income, reached ₹96,998 lakhs against ₹81,123 lakhs in the previous quarter and ₹89,340 lakhs in Q3FY25.

Financial Metric: Q3FY26 Q3FY25 Change (%)
Revenue from Operations: ₹95,015 lakhs ₹88,161 lakhs +7.76%
Total Income: ₹96,998 lakhs ₹89,340 lakhs +8.57%
Net Profit: ₹4,858 lakhs ₹2,038 lakhs +138.32%
Earnings Per Share (Basic): ₹34.48 ₹14.47 +138.29%

Segment-wise Performance

The poultry and poultry products segment emerged as the primary growth driver, benefiting from improved realisations in day-old chicks and grown-up birds sales. The segment reported revenue of ₹49,123 lakhs in Q3FY26. Animal health products contributed ₹8,798 lakhs, while the oilseed segment generated ₹32,577 lakhs in revenue.

Business Segment: Q3FY26 Revenue Segment Result
Poultry and Poultry Products: ₹49,123 lakhs ₹4,864 lakhs
Animal Health Products: ₹8,798 lakhs ₹2,347 lakhs
Oilseed: ₹32,577 lakhs ₹897 lakhs

Nine-Month Performance

For the nine-month period ended December 31, 2025, Venky's reported revenue from operations of ₹2,62,685 lakhs compared to ₹2,46,383 lakhs in the corresponding period last year. Net profit for the nine-month period stood at ₹10,332 lakhs, reflecting the company's consistent operational performance across segments.

Operational Highlights

Total expenses for Q3FY26 were ₹90,384 lakhs, with cost of materials consumed being the largest component at ₹60,807 lakhs. Employee benefits expense increased to ₹6,424 lakhs, while other expenses totaled ₹11,758 lakhs. The company maintained disciplined cost management while scaling operations.

Corporate Developments and Regulatory Compliance

The Board of Directors approved these audited financial results in their meeting held on February 9, 2026, which commenced at 10:30 AM IST and concluded at 1:30 PM IST. The results were reviewed by the Audit Committee before board approval and subsequently submitted to statutory auditors for their audit report.

The company has submitted its quarterly results to both the National Stock Exchange of India Limited (scrip code: VENKEYS) and Bombay Stock Exchange Limited (scrip code: 523261) under Regulation 33. Company Secretary and Compliance Officer Rohan Bhagwat signed the regulatory filings on February 9, 2026.

Historical Stock Returns for Venkys

1 Day5 Days1 Month6 Months1 Year5 Years
-6.92%-3.07%-5.54%-1.32%-21.91%-10.61%

Venky's (India) Limited Schedules Board Meeting for February 9, 2026 to Review Q3FY26 Financial Results

1 min read     Updated on 24 Jan 2026, 12:05 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Venky's (India) Limited has scheduled a board meeting for February 9, 2026, to consider and approve audited financial results for Q3FY26 quarter ended December 31, 2025. The meeting complies with SEBI Regulation 29 requirements, with formal notifications sent to NSE and BSE on January 24, 2026. The company trades under scrip codes VENKEYS on NSE and 523261 on BSE.

30782114

*this image is generated using AI for illustrative purposes only.

Venky's (India) Limited has officially announced that its Board of Directors will meet on February 9, 2026, to review and approve the company's audited financial results for the third quarter of fiscal year 2026. The meeting will specifically focus on the financial performance for the quarter ended December 31, 2025.

Regulatory Compliance and Meeting Details

The board meeting has been scheduled in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to provide advance notice to stock exchanges regarding board meetings where financial results will be considered.

Meeting Details: Information
Meeting Date: February 9, 2026
Day: Monday
Purpose: Consider and approve Q3FY26 audited financial results
Quarter End: December 31, 2025
Notification Date: January 24, 2026

Stock Exchange Notification

Venky's (India) Limited formally communicated the board meeting schedule to both major Indian stock exchanges through an official letter dated January 24, 2026. The company is listed on both the National Stock Exchange of India Limited under the scrip code VENKEYS and BSE Limited under the scrip code 523261.

Company Information

Venky's (India) Limited operates from its registered and corporate office located at 'Venkateshwara House', S.No. 114/A/2, Pune-Sinhagad Road, Pune-411030. The company holds the Corporate Identification Number (CIN) L01222PN1976PLC017422, indicating its incorporation in 1976 in Pune, Maharashtra.

The official communication was signed by Rohan Bhagwat, who serves as the Company Secretary and Compliance Officer, ensuring proper adherence to regulatory disclosure requirements. Investors and stakeholders can expect the company to announce its Q3FY26 financial performance following the board meeting on February 9, 2026.

Historical Stock Returns for Venkys

1 Day5 Days1 Month6 Months1 Year5 Years
-6.92%-3.07%-5.54%-1.32%-21.91%-10.61%

More News on Venkys

1 Year Returns:-21.91%